Neurotech International Limited (NTI.AX)
AUD 0.03
(6.25%)
AUD 0.03
(6.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -5867.00 AUD | -239.19% |
| 2023 | 4215.00 AUD | 100.79% |
| 2022 | -535.21 Thousand AUD | -124.2% |
| 2021 | -238.72 Thousand AUD | 56.31% |
| 2020 | -546.4 Thousand AUD | 52.82% |
| 2019 | -1.15 Million AUD | -1932.11% |
| 2018 | -56.99 Thousand AUD | 66.43% |
| 2017 | -169.79 Thousand AUD | 59.68% |
| 2016 | -421.14 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | -2.26 Million AUD | 0.0% |
| 2024 Q2 | -949.19 Thousand AUD | 0.0% |
| 2024 FY | -577.51 Thousand AUD | -13801.42% |
| 2023 FY | 4215.00 AUD | 100.79% |
| 2023 Q2 | -2.01 Million AUD | 0.0% |
| 2023 Q4 | -2.2 Million AUD | 0.0% |
| 2022 Q2 | -307.69 Thousand AUD | 0.0% |
| 2022 FY | -535.21 Thousand AUD | -124.2% |
| 2022 Q4 | -742.46 Thousand AUD | 0.0% |
| 2021 FY | -238.72 Thousand AUD | 56.31% |
| 2021 Q4 | -77.43 Thousand AUD | 0.0% |
| 2021 Q2 | -161.28 Thousand AUD | 0.0% |
| 2020 Q4 | -284.29 Thousand AUD | 0.0% |
| 2020 FY | -546.4 Thousand AUD | 52.82% |
| 2020 Q2 | -262.1 Thousand AUD | 0.0% |
| 2019 Q2 | -770.77 Thousand AUD | 0.0% |
| 2019 Q4 | -694.63 Thousand AUD | 0.0% |
| 2019 FY | -1.15 Million AUD | -1932.11% |
| 2018 Q4 | -82.16 Thousand AUD | 0.0% |
| 2018 FY | -56.99 Thousand AUD | 66.43% |
| 2018 Q2 | 25.16 Thousand AUD | 0.0% |
| 2017 Q4 | -87.01 Thousand AUD | 0.0% |
| 2017 Q2 | -82.77 Thousand AUD | 0.0% |
| 2017 FY | -169.79 Thousand AUD | 59.68% |
| 2016 Q2 | 77.53 Thousand AUD | 100.0% |
| 2016 Q1 | 38.76 Thousand AUD | 0.0% |
| 2016 Q3 | - AUD | -100.0% |
| 2016 FY | -421.14 Thousand AUD | 0.0% |
| 2016 Q4 | 82.68 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | 100.167% |
| Adherium Limited | -640.83 Thousand AUD | 99.084% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 100.011% |
| Atomo Diagnostics Limited | 1.43 Million AUD | 100.408% |
| Anteris Technologies Ltd | 2.51 Million AUD | 100.233% |
| Control Bionics Limited | 3.67 Million AUD | 100.16% |
| CardieX Limited | 10.1 Million AUD | 100.058% |
| Compumedics Limited | 26.06 Million AUD | 100.023% |
| Cochlear Limited | 1.69 Billion AUD | 100.0% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 100.052% |
| Cyclopharm Limited | 4.49 Million AUD | 100.13% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 100.052% |
| Nova Eye Medical Limited | 20.19 Million AUD | 100.029% |
| HeraMED Limited | -504.09 Thousand AUD | 98.836% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 99.706% |
| ImpediMed Limited | 9 Million AUD | 100.065% |
| InhaleRx Limited | 1.2 Million AUD | 100.487% |
| LBT Innovations Limited | -2.91 Million AUD | 99.799% |
| Micro-X Limited | 5.73 Million AUD | 100.102% |
| OncoSil Medical Limited | 55.63 Thousand AUD | 110.546% |
| PolyNovo Limited | 36.08 Million AUD | 100.016% |
| Respiri Limited | 456.91 Thousand AUD | 101.284% |
| SomnoMed Limited | 55.13 Million AUD | 100.011% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 100.137% |
| Uscom Limited | 3.11 Million AUD | 100.188% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 97.836% |